Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques

Neurobiology of Aging

Volumn 35, Issue 5, 2014, Pages 990-1001

  Shin, Min Kyoo ^a   Kim, Hong Gi ^a   Baek, Seung Hyun ^a   Jung, Woo Ram ^a   Park, Dong Ik ^a   Park, Jong Sung ^a   Jo, Dong Gyu ^a   Kim, Kil Lyong ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta; Brain derived Neurotrophic Factor; Cognition; Peptide

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID BETA; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; PEPTIDE;

1-METHYL-4-PHENYLPYRIDINIUM; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HUMANS; LEARNING; MEMORY; MICE; MOLECULAR TARGETED THERAPY; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID;

EID: 84893723488     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.10.091     Document Type: Article

References (50)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 2003, 60:387-392.
2. Aicardi G., Argilli E., Cappello S., Santi S., Riccio M., Thoenen H., Canossa M. Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A 2004, 101:15788-15792.
3. Almeida R.D., Manadas B.J., Melo C.V., Gomes J.R., Mendes C.S., Grãos M.M., Carvalho R.F., Carvalho A.P., Duarte C.B. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 2005, 12:1329-1343.
4. Arancibia S., Silhol M., Mouliere F., Meffre J., Hollinger I., Maurice T., Tapia-Arancibia L. Protective effect of BDNF against beta-amyloid induced neurotoxicity invitro and invivo in rats. Neurobiol. Dis. 2008, 31:316-326.
5. Billings L.M., Oddo S., Green K.N., McGaugh J.L., LaFerla F.M. Intraneuronal abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
6. Blurton-Jones M., Kitazawa M., Martinez-Coria H., Castello N.A., Muller F.J., Loring J.F., Yamasaki T.R., Poon W.W., Green K.N., LaFerla F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A 2009, 106:13594-13599.
7. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J.Neurosci. Res. 1993, 35:567-576.
8. Caccamo A., Maldonado M.A., Bokov A.F., Majumder S., Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A 2010, 107:22687-22692.
9. Chang L., Karim M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
10. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 2003, 4:299-309.
11. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
12. Corona C., Masciopinto F., Silvestri E., Viscovo A.D., Lattanzio R., Sorda R.L., Ciavardelli D., Goglia F., Piantelli M., Canzoniero L.M., Sensi S.L. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis. 2010, 1:e91.
13. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J.Biol. Chem. 2002, 277:32046-32053.
14. Devi L., Ohno M. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 2012, 37:434-444.
15. Franklin K.B., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
16. Gartner A., Staiger V. Neurotrophin secretion from hippocampal neurons evoked by long-term-potentiation-inducing electrical stimulation patterns. Proc. Natl. Acad. Sci. U.S.A 2002, 99:6386-6391.
17. Glasky A.J., Melchior C.L., Pirzadeh B., Heydari N., Ritzmann R.F. Effect of AIT-082, a purine analog, on working memory in normal and aged mice. Pharmacol. Biochem. Behav. 1994, 47:325-329.
18. Glasky, M.S., Conner, J.M., Tuszynski, M.H., 2001. Oral Administration of AIT-082 Stimulates BDNF and NGF Expression inVivo in Rats. Society for Neuroscience's 31st Annual Meeting. San Diego, p. 137.10.
19. Holsinger R.M., Schnarr J., Henry P., Castelo V.T., Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res. Mol. Brain Res. 2000, 76:347-354.
20. Hoshino T., Murao N., Namba T., Takehara M., Adachi H., Katsuno M., Sobue G., Matsushima T., Suzuki T., Mizushima T. Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. J.Neurosci. 2011, 31:5225-5234.
21. Jourdi H., Hamo L., Oka T., Seegan A., Baudry M. BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices. Neuropharmacology 2009, 56:876-885.
22. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736.
23. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J.Neurosci. Methods 1987, 20:83-90.
24. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996, 19:289-317.
25. Loebrich S., Nedivi E. The function of activity-regulated genes in the nervous system. Physiol. Rev. 2009, 89:1079-1103.
26. Marder K., Tang M.X., Cote L., Stern Y., Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch. Neurol. 1995, 52:695-701.
27. Massa S.M., Yang T., Xie Y., Shi J., Bilgen M., Joyce J.N., Nehama D., Rajadas J., Longo F.M. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J.Clin. Invest. 2010, 120:1774-1785.
28. Mattson M.P. Advances fuel Alzheimer's conundrum. Nat. Genet. 1997, 17:254-256.
29. Michalski B., Fahnestock M. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res. Mol. Brain Res. 2003, 111:148-154.
30. Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol. 2008, 18:240-252.
31. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J.Neurosci. Methods 1984, 11:47-60.
32. Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., Wang L., Blesch A., Kim A., Conner J.M., Rockenstein E., Chao M.V., Koo E.H., Geschwind D., Masliah E., Chiba A.A., Tuszynski M.H. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 2009, 15:331-337.
33. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
34. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., Teng K.K., Yung W.H., Hempstead B.L., Lu B. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487-491.
35. Park D.I., Kim H.G., Jung W.R., Shin M.K., Kim K.L. Mecamylamine attenuates dexamethasone-induced anxiety-like behavior in association with brain derived neurotrophic factor upregulation in rat brains. Neuropharmacology 2011, 61:276-282.
36. Peng S., Wuu J., Mufson E.J., Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J.Neurochem. 2005, 93:1412-1421.
37. Peng Y., Sun J., Hon S., Nylander A.N., Xia W., Feng Y., Wang X., Lemere C.A. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. J.Neurosci. 2010, 30:8180-8189.
38. Procter A.W. Abnormalities in Non-cholinergic Neurotransmitter Systems in Alzheimer's Disease. Dementia 2000, 433-442. Edward Arnold, Oxford. second ed. J. O'Brien, D. Ames, A. Burns (Eds.).
39. Rossler O.G., Giehl K.M., Thiel G. Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase. J.Neurochem. 2004, 88:1240-1252.
40. Saito T., Suemoto T., Brouwers N., Sleegers K., Funamoto S., Mihira N., Matsuba Y., Yamada K., Nilsson P., Takano J., Nishimura M., Iwata N., Van Broeckhoven C., Ihara Y., Saido T.C. Potent amyloidogenicity and pathogenicity of Aβ43. Nat. Neurosci. 2011, 14:1023-1032.
41. Schindowski K., Belarbi K., Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav. 2008, 1:43-56.
42. Schneider J.S., Kovelowski C.J. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res. 1990, 519:122-128.
43. Schratt G.M., Nigh E.A., Chen W.G., Hu L., Greenberg M.E. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J.Neurosci. 2004, 24:7366-7377.
44. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 1994, 17:489-517.
45. Shin M.K., Kim H.G., Kim K.L. Anovel trimeric peptide, neuropep-1-stimulating brain-derived neurotrophic factor expression in rat brain improves spatial learning and memory as measured by the y-maze and morris water maze. J.Neurochem. 2011, 116:205-216.
46. Tanila H., Björklund M., Riekkinen P. Cognitive changes in mice following moderate MPTP exposure. Brain Res. Bull. 1998, 45:577-582.
47. Tao X., Finkbeiner S., Arnold D.B., Shaywitz A.J., Greenberg M.E. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726.
48. Tapley P., Lamballe F., Barbacid M. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 1992, 7:371-381.
49. Targum S.D., Wieland D.S., Glasky M.S., Glasky A.J. Evaluation of AIT-082 in Patients with Mild to Moderate Senile Dementia of the Alzheimer's Type. Eur. Cong. Neuropsychopharmacol 1999, Sept 21-24; London, UK.
50. Zuccato C., Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol. 2009, 5:311-322.